A new study has found biological sex plays a significant role in how bodies fight viral infections, with male subjects showing markedly worse outcomes.
Researchers at McMaster University discovered male mice suffered more severe symptoms than females when infected with influenza, COVID-19 and West Nile virus, according to findings published in the Journal of Infectious Diseases. The males also showed significantly higher susceptibility to neurological complications including weakness and paralysis. Professor Ali Ashkar, 47, the principal investigator, said the team initially suspected the male mice had received higher viral loads.
“Both the males and females were infected under the same conditions – they were nearly genetically identical, they were the exact same age and they were infected with the same virus taken from the same vial in equal amounts,” Ashkar said, via the outlet.
“It made no sense for there to be such a huge difference in how the disease presented.”

The controlled conditions ruled out dosage or genetic variation as explanations for the disparity. Ashkar continued: “It’s becoming more and more accepted in the field that the outcomes of acute viral infections typically differ between males and females.”
“The male immune system seems to respond more strongly to these infections, and as a consequence, the damage or inflammation to the site of infection is often more severe,” he added.
Ashkar said the findings carry immediate clinical implications. “From now on, for any acute viral infection, it’s important for physicians to control inflammation early in male patients. We already have a lot of approved and effective anti–inflammatory medications, so we don’t necessarily need new interventions to do this.”
“We just need to acknowledge that male patients might be more susceptible to severe disease and tailor our treatment plans accordingly,” he concluded.

The study lands amid broader scrutiny of gender disparities in medical treatment. Separate recent US-based research found women’s pain is frequently assessed as milder than men’s even when both report identical injury levels, with female patients more likely to be directed toward psychotherapy over medication. Both male and female healthcare providers showed this assessment bias, that study revealed.
The term “man flu” has long circulated in popular culture as a dismissive label for men perceived as exaggerating minor cold symptoms. The McMaster findings suggest the phenomenon may have roots in measurable biological differences rather than behavioral tendencies alone. The research focused specifically on immune response patterns rather than self-reported symptom severity.
The Journal of Infectious Diseases published the team’s full results without specifying a timeline for potential human clinical trials building on the mouse-model findings.

